ASIA’S #1 CGT EVENT:

CELEBRATING 9 YEARS OF EXCELLENCE FROM DISCOVERY TO COMMERCIALISATION

10 - 11 September 2025 | Sheraton Towers Singapore

GET YOUR TICKET

Co-located with

Into its 9th edition, Cell and Gene Therapy World Asia has firmly established itself as Asia's THE cell and gene therapy gathering for new partnerships, ideas and knowledge. We are proud to continue the meeting platform where Asia's growing cell and gene therapy industry is at the forefront, receiving more and more global attention on its fast advancement in new therapies, R&D and biomanufacturing.

Key Themes & Topics

Biomedical Advancements & Innovations

The event explores the latest breakthroughs in biomedical research and technology, highlighting how cutting-edge innovations are transforming healthcare and improving patient outcomes. Discussions will cover emerging medical technologies, advancements in diagnostics, and the future of personalized medicine.

Biopharmaceutical Manufacturing

With the growing demand for high-quality and efficient drug production, the conference delves into modern manufacturing techniques, process optimization, and the integration of automation and AI in pharmaceutical production. Experts will share insights on streamlining operations, ensuring product consistency, and scaling up production to meet global healthcare needs.

Vaccine Development & Deployment

The latest advancements in vaccine research and manufacturing will be a major focus, covering everything from new vaccine formulations to strategies for rapid deployment. Speakers will discuss the challenges of global vaccine distribution, the role of mRNA technology, and innovative approaches to improving accessibility and affordability.

Regulatory & Compliance Frameworks

As the biopharmaceutical industry continues to evolve, regulatory requirements remain a crucial aspect of drug development and commercialization. Sessions will address the latest policies, compliance challenges, and strategies for navigating complex regulatory landscapes across different regions.

Collaborations & Networking

The event provides a platform for key industry players, researchers, and policymakers to connect and exchange ideas. Topics will include public-private partnerships, industry collaborations, and the role of government initiatives in supporting research and development. Strengthening networks and fostering international cooperation will be key discussion points.

Sustainability & Future Trends

The industry is moving towards more sustainable and environmentally friendly practices, and this theme will highlight innovative solutions for reducing waste, improving energy efficiency, and adopting green technologies. Additionally, experts will share insights on future trends, investment opportunities, and the next big breakthroughs shaping the future of biopharmaceuticals.

What to Expect at the 9th Annual Cell & Gene Therapy World Asia 2025

Attendees

Join over 500 professionals at the 9th Annual Cell & Gene Therapy World Asia! This is your chance to connect with key industry players, expand your network, and engage in high-level discussions that will shape the future of biologics.

Companies

Meet 150 leading companies driving innovation in the biologics sector. Whether you're looking for new partners or exploring the latest breakthroughs, this is the perfect platform to discover what’s next in the industry.

Speakers

Gain exclusive insights from 50 expert speakers who are shaping the future of biologics. Learn from the best in the field as they share cutting-edge knowledge, practical solutions, and emerging trends you can’t afford to miss.

Testimonials

“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”

West Pharmaceutical Services Korea

“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”

West Pharmaceutical Services Korea

“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”

West Pharmaceutical Services Korea

“Thank you for impactful events arranged for Korean attendees and giving us opportunities to have meaningful discussion with customers.”

West Pharmaceutical Services Korea

Into its 9th edition, Cell and Gene Therapy World Asia has firmly established itself as Asia's THE cell and gene therapy gathering for new partnerships, ideas and knowledge. We are proud to continue the meeting platform where Asia's growing cell and gene therapy industry is at the forefront, receiving more and more global attention on its fast advancement in new therapies, R&D and biomanufacturing.

WHO

C-Suites, Heads, Presidents, Directors, VPs, of R&D, Process Development and Manufacturing, Cell & Gene Therapy, Regenerative Medicines, Quality Control and Assurance from Cell & Gene Therapy Companies from Asia and the rest of the World.

WHAT

Evaluate the best practices, latest strategies, technologies and solutions in building a quality cell & gene therapy treatments through Asia's clinical trials and markets.

WHY

The Asia-Pacific (APAC) region played a substantial role in the global revenue of Cell and Gene Therapies (CGT), contributing over 26% in 2021. Projections indicate a robust expansion with a compound annual growth rate (CAGR) of 21% from 2021 to 2027, culminating in a market size of US$4 billion. Additionally, the Cell & Gene Biomanufacturing sector is poised for remarkable growth, with an expected CAGR of 17.88% from 2022 to 2031, witnessing a substantial increase from $1.96 billion to an impressive $8.60 billion. Notably, significant investments from governments, pharmaceutical leaders, and academic institutions in the APAC region are paving the way for innovative breakthroughs in medical treatments, fostering an increased demand for advanced biomanufacturing solutions.

CONTACT

Ana Laxamana, Business Development Manager

e: [email protected]

m: +65 6983 6132

Nathan Grace Niño, Business Development Manager

e: [email protected]

m: +65 6983 6134 | +44 161 552 8521

Share With Your Network